TScan Therapeutics
TCRX
$8.98
Share price
0.90%
Change (1 day)
151.54%
Change (1 year)
Categories
TScan Therapeutics (TCRX) - Cash on Hand
Cash on Hand as of December 2023 : $0.19 B
According to TScan Therapeutics's latest financial reports the company has $0.19 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
TScan Therapeutics - Cash on Hand chart (from 2020 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.19 B | 60% |
| 2022-12-31 | $0.12 B | -25.64% |
| 2021-12-31 | $0.16 B | 363.93% |
| 2020-12-31 | $34.79 M | -16.7% |
| 2019-12-31 | $41.76 M |